PDF(Pubmed)
Abstract：
Struma ovarii is a rare type of ovarian teratoma primarily composed of over 50% thyroid tissue. Its occurrence is reported in 2-5% of all ovarian teratomas, with approximately 0.5% to 10% showing malignant transformation. Managing it during pregnancy poses significant challenges as pregnancy can promote the growth of malignant struma ovarii due to elevated levels of ovarian and pregnancy-related hormones, including estrogen, progesterone, and human chorionic gonadotrophin (hCG). Most ovarian tumors, including struma ovarii, are detected during routine ultrasonography in the first and second trimesters, often as acute emergencies. Diagnosis during pregnancy is rare, with some cases incidentally discovered during cesarean section when inspecting the adnexa for ovarian cysts. This review explores the diagnostic, management, and therapeutic approaches to struma ovarii during pregnancy.
摘要：
卵巢Struma是一种罕见的卵巢畸胎瘤，主要由50％以上的甲状腺组织组成。据报道，其发生率占所有卵巢畸胎瘤的2-5％，大约0.5%到10%显示恶变。在怀孕期间管理它构成了重大挑战，因为怀孕可以促进恶性卵巢的生长，由于卵巢和妊娠相关激素水平升高，包括雌激素,黄体酮,和人绒毛膜促性腺激素（hCG）。大多数卵巢肿瘤，包括卵巢甲状腺肿,在妊娠早期和中期的常规超声检查中检测到，通常是急性紧急情况。怀孕期间的诊断很少见，有些病例是在剖腹产时在检查附件是否有卵巢囊肿时偶然发现的。这篇评论探讨了诊断，管理,以及妊娠期卵巢甲状腺肿的治疗方法。
